title: Letter by Keidar and Gamliel-Lazarovich regarding article, "Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial".
authors.forename: Shlomo
authors.initials: S
authors.lastname: Keidar
authors.forename: Aviva
authors.initials: A
authors.lastname: Gamliel-Lazarovich
mesh_terms: D001794:Blood Pressure / Q000187:drug effects*; D019405:Cytochrome P-450 CYP11B2 / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology*; D008297:Male
chemical_list: D004791:Enzyme Inhibitors; D019405:Cytochrome P-450 CYP11B2